NYSE-listed shares of Novo Nordisk surged 4% on Wednesday morning after the Danish pharmaceutical giant posted better-than-expected fourth-quarter earnings. The company reported earnings of 6.34 ...
Some results have been hidden because they may be inaccessible to you